The study examined airway abnormalities in 69 patients from Denver and Los Angeles, 42 with RA antibodies and no joint symptoms, 15 with no RA antibodies or joint symptoms, and 12 with early RA.

And yet no effects of rheumatoid arthritis therapy, remains in the aftermath of the inflammation and treatment, integrated treatment to relieve symptoms and the patients have a certain effect.

Celecoxib-containing products are currently authorised in the European Union for the treatment of the symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.